missing translation for 'onlineSavingsMsg'
Learn More
Learn More
enQuireBio™ Recombinant Human Leptin tA Protein
A cDNA sequence encoding the Leptin tA was constructed and used to recombinantly synthesize the protein.
131.00 € - 203.00 €
Specifications
Name | Leptin tA Protein |
---|---|
Regulatory Status | Research Use Only |
Endotoxin Concentration | < 1.0 EU per ug protein as determined by the LAL method. |
Biological Activity | Capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its in vitro activity is 6-8 fold lower than the non-pegylated antagonist but in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. Its in vivo activity compared to that of PEG-MLA is 9-27 fold higher. |
Product Type | Recombinant Protein |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
15985098
|
enQuireBio™
QP10766-5UG |
5 μg |
131.00 €
5µg |
Estimated Shipment: 10-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
15975098
|
enQuireBio™
QP10766-20UG |
20 μg |
203.00 €
20µg |
Estimated Shipment: 10-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
Specifications
Leptin tA Protein | |
< 1.0 EU per ug protein as determined by the LAL method. | |
Recombinant Protein | |
E. coli | |
The protein was lyophilized from a concentrated (0.65 mg/ml) solution with 0.003mM NaHCO3. |
Research Use Only | |
Capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its in vitro activity is 6-8 fold lower than the non-pegylated antagonist but in vivo it has profound weight gain effect (as compared to the non-pegylated antagonist), resulting mainly from increased food intake. Its in vivo activity compared to that of PEG-MLA is 9-27 fold higher. | |
Human | |
Untagged | |
Greater than 98.0% as determined by: (a) Gel filtration analysis. (b) Analysis by SDS-PAGE. |